President Trump is set to announce a drug-pricing deal with Pfizer, where Pfizer will voluntarily sell its medications through Medicaid at reduced prices and invest $70 billion in the U.S. Additionally, Trump unveiled a direct-to-consumer website, TrumpRx, for Americans to buy drugs. Pfizer plans to offer some drugs at reduced rates and all drugs to Medicaid at a 'most favored nation' price. The initiative aims to lower drug prices and increase accessibility. Shares of Pfizer, Merck, Bristol Myers Squibb, and other drug companies rose following the announcement. The announcement signifies a significant collaboration between the government and pharmaceutical giants to address drug pricing concerns.